Alopecia involves progressive miniaturization of the hair follicle and the loss of its ability to renew itself throughout the hair cycle. A recent systematic review, published in Tissue and Cell, brought together experimental and clinical studies on the secretome of adipose tissue-derived mesenchymal cells (AT-MSCs): the collection of growth factors, cytokines, and extracellular vesicles, such as exosomes, released by these cells.
The authors note that current approaches to hair loss often provide partial or temporary benefits because they act on only a few biological pathways. Meanwhile, research on mesenchymal cells indicates that much of their biological activity comes from paracrine signaling, rather than direct integration of the cells into tissue. This has fueled growing interest in studying what these cells secrete.
Adipose tissue is a particularly well-studied source: it is abundant, relatively easy to obtain during liposuction, and has a robust secretory profile.
Widowati W, Putri LIR, Seipalla F, Soraya F, Pertiwi AP, Restika N, Trismayenny R, Andromeda AG, Azis R, Pratama R, Zan E. "Hair regeneration in alopecia using adipose-derived mesenchymal stem cells secretome: A systematic review of experimental and clinical evidence." Tissue and Cell. 2027;104(Pt 2):103872. DOI: 10.1016/j.tice.2026.103872.
| Level of evidence | Finding described by the authors |
|---|---|
| Cells in culture | Expansion of dermal papilla cells and activation of the Wnt/β-catenin pathway, which is central to follicle growth. |
| Animal models | Faster transition from the resting phase (telogen) to the growth phase (anagen), higher follicle density, and improved vascularization around the follicles. |
| Preliminary clinical studies | Increased hair density and thickness, particularly when the secretome was combined with microneedling or conventional approaches. |
| Proposed mechanisms | Angiogenic factors (VEGF, IGF-1, HGF), immune modulation, and inhibition of apoptosis in the follicular microenvironment. |
The authors themselves emphasize that secretome production techniques, doses, and clinical study designs vary widely, limiting interpretation of the data. Confirming safety, efficacy, and clinical relevance requires large, well-controlled clinical trials and standardized production processes.
Cryopraxis perspective: the review reinforces the position of adipose tissue as one of the most extensively studied biological materials in regenerative medicine. At the same time, it shows that the use of the secretome for hair regeneration remains at the research stage and depends on standardization.
LipAge enables cryopreservation of a portion of the adipose tissue obtained during an already planned liposuction procedure, at a Cell Technology Center licensed by ANVISA (Brazil's health regulatory agency). This is autologous material, stored for future use upon medical indication, in accordance with the applications that are regulated and available at that time.
LipAge does not offer secretome or products for alopecia. This newsletter summarizes a third-party scientific publication for educational purposes; the reported results belong to the authors and do not constitute a promise of results. Any clinical use depends on medical assessment and applicable regulations.
Contact the Cryopraxis team to learn about collection and cryopreservation protocols.
WhatsApp Read the article